Landmark gene therapy for hereditary blindness closes in on FDA approval

Back in August, the FDA approved the first gene therapy for general use in the United States. That particular treatment, for cancer, was beset by controversy due to its exorbitant price tag and potential side effects. Now another gene therapy is on the cusp of approval, this time to treat a form of hereditary blindness. If given the tick by the FDA, this therapy could pave the way for a whole host of treatments for genetically-based vision problems... Continue Reading Landmark gene therapy for hereditary blindness closes in on FDA approval Category: Medical Tags: Blindness Eye Genetics Vision Related Articles: Eye2TV adapter aims to improve the TV viewing experience for colorblind users Microsoft app caters to the colorblind Blindness strikes three women after iffy stem-cell treatments Soft artificial retina m

Landmark gene therapy for hereditary blindness closes in on FDA approval

Back in August, the FDA approved the first gene therapy for general use in the United States. That particular treatment, for cancer, was beset by controversy due to its exorbitant price ...

Mon 13 Nov 17 from Gizmag

Genetic treatment for blindness may soon be reality

Patients who had lost their sight to an inherited retinal disease could see well enough to navigate a maze after being treated with a new gene therapy, according to research presented today ...

Sat 11 Nov 17 from Medical Xpress

Genetic treatment for blindness may soon be reality, Sat 11 Nov 17 from ScienceDaily

Genetic treatment for blindness may soon be reality, Fri 10 Nov 17 from Eurekalert

Gene Therapy Offers Hope for Inherited Retinal Disorder (CME/CE)

(MedPage Today) -- Treatment improved long-term visual function in Leber congenital amaurosis

Wed 15 Nov 17 from MedPageToday

Seeing the light

New gene therapy helps partially restore vision lost to rare disease

Sat 11 Nov 17 from The Hindu

  • Pages: 1

Bookmark

Bookmark and Share